Concepedia

Author

Hans Chulhee Lee

The University of Texas MD Anderson Cancer Center

Also Known As

Hans C. Lee, Hans Chulhee Lee, Lee, Hans C.

25

Publications

110

Citations

6

H-Index

28

Concepts

All Affiliations

The University of Texas MD Anderson Cancer CenterUniversity of Wisconsin Carbone Cancer CenterPrincess Margaret Cancer CentreUniversity of PennsylvaniaGlaxoSmithKline (United States)
HC

About

Hans Chulhee Lee is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, cancer research, and clinical trials.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

56

2

Immunology

3

3

56

3

Health Sciences

1

1

27

4

Cell Biology

1

1

12

5

Molecular Medicine

1

1

12

Hans Chulhee Lee

×

5

Publications

96

Citations

5

H-Index

YearCitations

Pivotal DREAMM-2 study: Single-agent belantamab mafodotin (GSK2857916) in patients with relapsed/refractory multiple myeloma (RRMM) refractory to proteasome inhibitors (PIs), immunomodulatory agents, and refractory and/or intolerant to anti-CD38 monoclonal antibodies (mAbs).

Sagar Lonial, Hans Chulhee Lee, Ashraf Badros,

Journal of Clinical Oncology

2020

27

Molecular and genetic biomarkers implemented from next-generation sequencing provide treatment insights in clinical practice for Waldenström macroglobulinemia

Yingjun Wang, Vasantha Lakshmi Gali, Zijun Y. Xu‐Monette,

Neoplasia

2021

27

DREAMM-2: Single-agent belantamab mafodotin (GSK2857916) in patients with relapsed/refractory multiple myeloma (RRMM) and renal impairment.

Hans Chulhee Lee, Adam D. Cohen, Ajai Chari,

Journal of Clinical Oncology

2020

17

Quality of life and cancer worry in a follow-up cohort of patients with asymptomatic monoclonal gammopathies.

Michelle Ann Theobald Hildebrandt, Rashida Callender, Alem A. Belachew,

Journal of Clinical Oncology

2018

13

DREAMM-2: Single-agent belantamab mafodotin (GSK2857916) in patients with relapsed/refractory multiple myeloma (RRMM) and high-risk (HR) cytogenetics.

Adam D. Cohen, Suzanne Trudel, Sagar Lonial,

Journal of Clinical Oncology

2020

12

Page 1